Technetium-99M全球市场规模、份额、趋势和成长分析报告（2026-2034）

预计Technetium-99m的市场规模将从2025年的71.1亿美元成长到2034年的101亿美元，2026年至2034年的复合年增长率为3.97%。

由于Technetium-99m在核子医学扫描术诊断的广泛应用，其全球市场在医疗领域的重要性日益凸显。Technetium-99m是一种放射性同位素，常用于骨骼扫描、心臟影像影像和癌症筛检等诊断程序。其半衰期短且成像清晰，使其成为医学诊断中最常用的同位素之一。

多种因素正在推动Technetium-99m市场的成长。对精准诊断影像和疾病早期检测日益增长的需求，正在扩大核子医学技术的应用范围。此外，影像设备和放射性药物生产技术的进步，也提高了基于Technetium的诊断程序的可及性和有效性。

未来几年，随着医疗系统将早期诊断和疾病管理置于优先地位，Technetium-99m市场预计将持续成长。核子医学和放射性药物技术的探索有望提高诊断影像的准确性和病人安全。此外，发展中地区医疗基础设施的扩建预计将增加核医诊断检测的可近性。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球Technetium-99M市场：依临床服务划分

• 市场分析、洞察与预测
• 骨骼扫描
• 肾臟扫描
• 心臟扫描
• 神经系统扫描

第五章：全球Technetium-99m市场：依同位素应用划分

• 市场分析、洞察与预测
• 伽马摄影机
• 单光子发射电脑断层扫描（SPECT）

第六章：全球Technetium-99M市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 其他的

第七章：全球Technetium-99M市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Advanced Accelerator Applications SA
  • Advanced Cyclotron SystemsInc
  • Bayer AG
  • GE Healthcare
  • Philips Healthcare,
  • Siemens Healthineers
  • Eckert & Ziegler
  • IBA Radiopharma Solutions
  • Medi-Radiopharma Kft
  • Lantheus HoldingsInc
  • NordionInc
  • NTP Radioisotopes SOC Ltd
  • Jubilant Life Sciences
  • SDS Lifesciences Pvt. Ltd
  • BWX TechnologiesInc

The Technetium-99m Market size is expected to reach USD 10.10 Billion in 2034 from USD 7.11 Billion (2025) growing at a CAGR of 3.97% during 2026-2034.

The global technetium-99m market has gained importance in the healthcare sector due to its widespread use in nuclear medicine imaging. Technetium-99m is a radioactive isotope commonly used in diagnostic procedures such as bone scans, cardiac imaging, and cancer detection. Its short half-life and ability to produce clear imaging results make it one of the most widely used isotopes in medical diagnostics.

Several factors are driving the growth of the technetium-99m market. Increasing demand for accurate diagnostic imaging and early disease detection has expanded the use of nuclear medicine technologies. Additionally, advancements in imaging equipment and radiopharmaceutical production have improved the availability and effectiveness of technetium-based diagnostic procedures.

In the coming years, the technetium-99m market is expected to continue growing as healthcare systems prioritize early diagnosis and improved disease management. Research in nuclear medicine and radiopharmaceutical technologies may enhance imaging accuracy and patient safety. Furthermore, expanding healthcare infrastructure in developing regions will likely increase access to nuclear diagnostic procedures.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Clinical Services

• Bone Scan
• Renal Scan
• Cardiac Scan
• Neurology Scan

By Isotopic Application

• Gamma Camera
• Single Photon Emission Computed Tomography (SPECT)

By End User

• Hospitals
• Diagnostic Centers
• Others

COMPANIES PROFILED

• Advanced Accelerator Applications SA, Advanced Cyclotron Systems, Inc, Bayer AG, GE Healthcare, Philips Healthcare,, Siemens Healthineers, Eckert Ziegler, IBA Radiopharma Solutions, MediRadiopharma Kft, Lantheus Holdings, Inc, Nordion, Inc, NTP Radioisotopes SOC Ltd, Jubilant Life Sciences, SDS Lifesciences Pvt Ltd, BWX Technologies, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TECHNETIUM-99M MARKET: BY CLINICAL SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Clinical Services
• 4.2. Bone Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Renal Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cardiac Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Neurology Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TECHNETIUM-99M MARKET: BY ISOTOPIC APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Isotopic Application
• 5.2. Gamma Camera Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Single Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TECHNETIUM-99M MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TECHNETIUM-99M MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Clinical Services
  • 7.2.2 By Isotopic Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Clinical Services
  • 7.3.2 By Isotopic Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Clinical Services
  • 7.4.2 By Isotopic Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Clinical Services
  • 7.5.2 By Isotopic Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Clinical Services
  • 7.6.2 By Isotopic Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TECHNETIUM-99M INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Advanced Accelerator Applications S.A
  • 9.2.2 Advanced Cyclotron SystemsInc
  • 9.2.3 Bayer AG
  • 9.2.4 GE Healthcare
  • 9.2.5 Philips Healthcare,
  • 9.2.6 Siemens Healthineers
  • 9.2.7 Eckert & Ziegler
  • 9.2.8 IBA Radiopharma Solutions
  • 9.2.9 Medi-Radiopharma Kft
  • 9.2.10 Lantheus HoldingsInc
  • 9.2.11 NordionInc
  • 9.2.12 NTP Radioisotopes SOC Ltd
  • 9.2.13 Jubilant Life Sciences
  • 9.2.14 SDS Lifesciences Pvt. Ltd
  • 9.2.15 BWX TechnologiesInc